Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Dont know history of pxen, just seen rns. Genuine question.
is this whats happened here?
https://twitter.com/GaryNTrader/status/1623579338900742146
@GaryNTrader
#ARB Peter Wall doing a runner - resigned as CEO and interim chairman!
@doit4thetwins
Replying to
@GaryNTrader
- I’d do the same
thought that
bottom was when Armistice closed their short. added some after short closed. was wrong
second bottom was when Armistice bought @3.29 & was wrong again.
have not added/sold yet since news
Lombard still holding some with higher average & no action from CMS + A&B (HK) so far.
Holding a stick with both ends manured
looks at least 15% holding off
"As of the date hereof, we have been notified by a shareholder purporting to represent shareholders holding over 15% of our outstanding shares that they may not support and approve the transactions contemplated by the Arrangement Agreement."
https://stocktwits.com/Nico1980/message/501572499
or
https://otp.investis.com/clients/us/midatech/SEC/sec-show.aspx?Type=page&FilingId=16260707-3234-7875&CIK=0001643918&Index=20000
FDA okays ProstatID software for detecting prostate cancer in MRI
https://pharmaphorum.com/news/fda-okays-prostatid-software-for-detecting-prostate-cancer-in-mri/
Rank Who
1 rightback
2 ValJu
3 PM2022
4 iceman888
5 Casper786
6 saint-tropez
7 Uncanny
8 MaxHSpringer
9 Porky9
10 Fredd1eboy
11 MisterPositive
12 nomlungu
13 TRDR322
14 oldbaldy
15 applegarth
16 Bankfool
17 Teamhanz
18 EyeGuy
19 rhubarbmk2
20 roses
.
.
paul richards
@paulric46143425
Replying to
@ColdHotand
Trying that old 1 trade b@@@@@@ as well now HC.
We’ll let’s see.
12:58 PM · Aug 4, 2022·Twitter for iPhone
HotandColdStocks
@ColdHotand
Replying to
@paulric46143425
a scaffolder by trade eh i doubt it have you ever done a slung in a picture house muppet
1:22 PM · Aug 4, 2022·Twitter Web App
Cancer has already been discussed as a potential sequelae of long covid in the published biomedical literature
for example, here
https://pubmed.ncbi.nlm.nih.gov/33914346/
dont give up cancer stocks easily, imo
"17 cell cycle-related genes were up-regulated in SARS-CoV-2 patients [list] dysregulation in the expression of these genes is linked with various cancers, like
breast cancer,
endometrial cancer,
digestive tract cancer,
bone cancer,
skin cancer,
brain cancer,
lung cancer etc."
Of course related to valirx
not peer reeviewed yet,
surely fact checkers & experts here will do it and get this post removed
https://www.researchsquare.com/article/rs-1894265/v1
well, in short
Armistice Capital bought the bottom for long sufferers, SP should build on that
https://www.fca.org.uk/publication/data/short-positions-daily-update.xlsx
Animal model of human disease: endometriosis enhanced atherosclerosis
https://www.endonews.com/atherosclerosis-is-augmented-in-laboratory-mice-by-experimental-endometriosis
25 months since MTA with global Japanese pharmaceutical company
p11
" ? Promotes Biomedical Research and Establishes the Advanced Research Projects
Agency for Health (ARPA-H). The discretionary request includes $51 billion for the
National Institutes of Health (NIH), a $9 billion increase over the 2021 enacted level, to
continue to support research that enhances health, lengthens life, and reduces illness and
disability. Included in this increase is $6.5 billion to establish ARPA-H.
With an initial focus on cancer and other diseases such as diabetes and Alzheimer’s, this major
investment in Federal research and development would drive transformational innovation
in health research and speed application and implementation of health breakthroughs. "
The Central Government on Thursday more than doubled the price of domestically produced natural gas for the six months beginning tomorrow (1 April), reflecting a surge in global prices.
https://www.livemint.com/industry/energy/india-more-than-doubles-domestic-natural-gas-price-to-6-1-mmbtu-for-6-months-beginning-1-april-11648729140812.html
can a delaware company make it ,
Suzy full of confidence!
" Xtandi, a wonder drug for prostate cancer, was developed at UCLA with substantial funding from the taxpayers through the Pentagon and the National Institutes of Health.
UCLA has profited handsomely from the drug, to the tune of more than $520 million in royalties. The drug companies that acquired the manufacturing license, including Pfizer and the Tokyo firm Astellas Pharma, have also raked in billions in sales.
American taxpayers and prostate cancer patients haven’t done as well. Xtandi’s average wholesale price in the U.S. comes to $189,800 a year. "
Feb. 10, 2022
Michael Hiltzik
Event details
Please be advised that shareholders can exercise their Warrants to receive Ordinary share as per the terms below:
1 new ordinary share for each warrant exercised, at a price of £10 per share.
Shareholders have until 23rd February to make their election.
Please note, this is the final exercise opportunity.
Respond by 23/02/2022
Record date 28/02/2022
Announcement date 15/02/2022
Ex date 28/02/2022
Effective date28/02/2022